胃复安超声穴位导入预防化疗后恶心呕吐的疗效观察

Observation on the effect of ultrasoundacupoint introduction of metoclopramide on preventing nausea and vomiting after chemotherapy

目的:观察胃复安超声穴位导入预防化疗后恶心呕吐(CINV)的效果。方法:选取2018年6-12月拟行化疗并具有中高CINV风险的癌症患者170例,随机分为两组,各85例。对照组化疗期间应用常规止吐预防方案;试验组在常规止吐预防方案基础上应用足三里穴位超声导入。比较两组CINV控制情况。结果:试验组CINV控制总有效率明显优于对照组,差异有统计学意义(P<0.05)。结论:对具有化疗后CINV中高风险患者行胃复安足三里穴超声导入治疗,能明显减轻患者胃肠道反应。

Objective:To observe the effect of ultrasoundacupoint introduction of metoclopramide on preventing nausea and vomiting after chemotherapy(CINV).Methods:From June to December 2018,170 cancer patients who prepared for chemotherapy with moderate and high risk of CINV were selected,they were randomly divided into two groups with 85 cases in each group.The control group used routine anti-emetic prevention methods during chemotherapy.The experimental group applied Zusanli acupoint ultrasound introduction based on the conventional anti-emetic prevention methods.The the control situation of CINV between the two groups was compared.Results:The total effective rate of CINV control in the experimental group was better than the control group,the difference was statistically significant(P<0.05).Conclusion:Patients who have moderate and high risk of CINV after chemotherapy treated by Zusanli acupoint ultrasound introduction of metoclopramide can significantly alleviate the gastrointestinal reaction of patients.